Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy

Maria Angela Losi1, Emanuele Monda2, Raffaella Lombardi1

  • 1Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

PubMed

Insights

Left atrial diameter is a simple echocardiographic measure that can predict atrial fibrillation (AF) development in hypertrophic cardiomyopathy (HCM) patients. This measurement is more effective than the HCM-AF Score for identifying individuals at high risk for AF.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Medical Imaging

Background:

  • Atrial fibrillation (AF) is a common arrhythmia in hypertrophic cardiomyopathy (HCM) with significant prognostic implications.
  • Predicting AF development in HCM patients is crucial for timely intervention and improved outcomes.

Purpose of the Study:

  • To compare the predictive value of left atrial (LA) diameter measurement against the HCM-AF Score for AF development in HCM patients.
  • To identify simple and effective methods for risk stratification of AF in HCM.

Main Methods:

  • A cohort of 519 HCM patients without a history of AF was followed prospectively.
  • The primary endpoint was the documented development of AF via ECG.
  • Left atrial diameter and HCM-AF score were assessed and compared for their predictive accuracy using ROC curve analysis.

Main Results:

  • During a mean follow-up of 8 years, 19% of patients developed AF.
  • Patients who developed AF had larger LA diameters, greater LV wall thickness, and higher LV outflow tract obstruction.
  • Left atrial diameter demonstrated a significantly greater area under the ROC curve compared to the HCM-AF Score (p < 0.0001).

Conclusions:

  • Left atrial diameter is a powerful, standalone predictor of AF development in HCM.
  • A LA diameter > 46 mm at 5-year follow-up accurately predicts AF development, similar to an HCM-AF score >= 22.
  • This simple echocardiographic measure offers a valuable tool for risk-stratifying HCM patients for AF.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K